Nancy Simonian, MD, CEO, Syros Pharmaceuticals elaborates on the breakthrough discovery of super-enhancers, large groups of transcriptional enhancers that drive expression of genes that define cell identity. By identifying the most functionally important component of a cell, super-enhancers are a simple approach to find out what’s most critical for cell fate in the normal and diseased state.